BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kokudeva M, Vichev M, Naseva E, Miteva DG, Velikova T. Artificial intelligence as a tool in drug discovery and development. World J Exp Med 2024; 14(3): 96042 [PMID: 39312699 DOI: 10.5493/wjem.v14.i3.96042]
URL: https://www.wjgnet.com/2220-315x/full/v14/i3/96042.htm
Number Citing Articles
1
Pankaj Garg, Gargi Singhal, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Artificial Intelligence–Driven Computational Approaches in the Development of Anticancer DrugsCancers 2024; 16(22): 3884 doi: 10.3390/cancers16223884
2
K. Daqrouq, S. Alghamedi, S. Alwaseli, A. F. Alkhateeb, Sami Alghamdi, M. N. Ajour, A. S. Balamash, A. Milyani, K. Alharbi, A. M. Rushdi, Giovanni Angiulli. Impact of the Utilization of Artificial Intelligence in the Development of Electrical EngineeringJournal of Engineering 2025; 2025(1) doi: 10.1155/je/1390935
3
Razvan Onciul, Catalina-Ioana Tataru, Adrian Vasile Dumitru, Carla Crivoi, Matei Serban, Razvan-Adrian Covache-Busuioc, Mugurel Petrinel Radoi, Corneliu Toader. Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical ApplicationsJournal of Clinical Medicine 2025; 14(2): 550 doi: 10.3390/jcm14020550
4
Elisa Avolio, Barbara Bassani, Marzia Campanile, Khaled AK. Mohammed, Paola Muti, Antonino Bruno, Gaia Spinetti, Paolo Madeddu. Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?Pharmacological Reviews 2025; 77(2): 100033 doi: 10.1016/j.pharmr.2024.100033
5
Artificial intelligence in drug discovery and development: transforming challenges into opportunitiesDiscover Pharmaceutical Sciences 2025; 1(1) doi: 10.1007/s44395-025-00007-3
6
Vinay Kumar, Kunal Roy. Embracing the changes and challenges with modern early drug discoveryExpert Opinion on Drug Discovery 2025; 20(4): 419 doi: 10.1080/17460441.2025.2481259
7
Sara Laianny Ferreira Cunha, Maria de Jesus Costa das Neves , Franciélio Alves Silva , Raynara Beatriz Magalhães Morais , Luiza Sousa Oliveira , Beatriz Lisboa Pinto , Letícia Alves Santos , Kalynna Beatriz Araujo Diniz , Kamila Cristhine Bede Camilo , Karen Silva de Almeida . AVANÇOS NO DIAGNÓSTICO E TRATAMENTO DE DOENÇAS NEUROLÓGICAS: NOVAS ESTRATÉGIAS TERAPÊUTICAS E DESAFIOS CLÍNICOS NO CONTEXTO ATUALCognitus Interdisciplinary Journal 2025; 2(2): 353 doi: 10.71248/xmdf9133
8
AI-driven approaches in therapeutic interventions: Transforming RNA-seq analysis into biomarker discovery and drug developmentDrug Discovery Today 2025; 30(7): 104391 doi: 10.1016/j.drudis.2025.104391
9
Alaa Marwan-Abu-Taha. Elevating Research and Careers in the Development of Safer Drugs through Artificial IntelligenceChemical Research in Toxicology 2025; 38(3): 365 doi: 10.1021/acs.chemrestox.4c00423
10
Kathirvel Sekar, Kaviyarasi Renu, Sathishkumar Vinayagam, Devianjana Rajendran, Kamaraj Sattu. In Silico Development of PABA-substituted Pyrimidine Derivatives Targeting Mutant p53 for Precision Therapy in Oral Squamous Cell CarcinomaJournal of Advanced Oral Research 2025;  doi: 10.1177/23202068251330106
11
Somayah J. Jarallah, Fahad A. Almughem, Nada K. Alhumaid, Nojoud AL Fayez, Ibrahim Alradwan, Khulud A. Alsulami, Essam A. Tawfik, Abdullah A. Alshehri. Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovationInternational Journal of Pharmaceutics 2025; 680: 125789 doi: 10.1016/j.ijpharm.2025.125789